These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

973 related items for PubMed ID: 10091775

  • 1. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F, Comella P, Marcolin P, Russo Spena F, Biglietto M, Cartenì G, De Lucia L, Avallone A, Gravina A, Comella G.
    Cancer; 1999 Feb 15; 85(4):952-9. PubMed ID: 10091775
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F, Rosati G, De Rosa P, Avallone A, De Rosa V, De Lucia L, Comella P, Comella G.
    Oncology; 2002 Feb 15; 63(3):232-8. PubMed ID: 12381902
    [Abstract] [Full Text] [Related]

  • 3. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May 15; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 4. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.
    Oral Oncol; 2006 Aug 15; 42(7):675-84. PubMed ID: 16731029
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).
    Caponigro F, Comella P, Rivellini F, Avallone A, Budillon A, Di Gennaro E, Mozzillo N, Ionna F, De Rosa V, Manzione L, Comella G.
    Ann Oncol; 2000 May 15; 11(5):575-80. PubMed ID: 10907951
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O, Komatsu M.
    Cancer Chemother Pharmacol; 2010 Sep 15; 66(4):729-36. PubMed ID: 20033810
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Riva C, Lavieille JP, Schmerber S, Cuisnie O, Reyt E.
    Int J Oncol; 2000 Sep 15; 17(3):543-9. PubMed ID: 10938396
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
    Bensmaine M el-A, Guillot T, Bernal ET, Janot F, Sigal R, Domenge C, Wibault P, Armand JP, Cvitkovic E.
    Am J Clin Oncol; 1996 Aug 15; 19(4):356-62. PubMed ID: 8677904
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
    Wendt TG, Grabenbauer GG, Rödel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A.
    J Clin Oncol; 1998 Apr 15; 16(4):1318-24. PubMed ID: 9552032
    [Abstract] [Full Text] [Related]

  • 10. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK.
    J Clin Oncol; 1992 Aug 15; 10(8):1245-51. PubMed ID: 1634913
    [Abstract] [Full Text] [Related]

  • 11. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL, Chu PY, Tai SK, Wang YF, Yang MH, Wang LW, Lirng JF, Chang SY.
    Jpn J Clin Oncol; 2011 Oct 15; 41(10):1182-93. PubMed ID: 21862506
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR.
    J Natl Cancer Inst; 1992 Jun 03; 84(11):877-82. PubMed ID: 1375657
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.
    Cancer J Sci Am; 1997 Jun 03; 3(2):92-9. PubMed ID: 9099459
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer.
    Alba E, Sanchez-Chaparro MA, Alonso L, Ribelles N, Ramon Delgado J, Rueda A, Pablo Tenllado P, Solano J, Urquiza R.
    Am J Clin Oncol; 1996 Apr 03; 19(2):140-3. PubMed ID: 8610637
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 03; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.